Finasteride and PP405 Interaction
Finasteride and PP405 have a compatible interaction with 90% confidence. Completely different mechanisms of action. Finasteride blocks DHT production via 5-alpha reductase inhibition, while PP405 targets hair follicle stem cell metabolism via MPC inhibition. Combination could be synergistic by addressing both hormonal miniaturization and stem cell dormancy simultaneously. Both compounds affect the skin, so monitoring these systems is recommended.
Compound Profiles
Finasteride
5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH
Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).
View full profilePP405
MPC Inhibitor | Hair Follicle Stem Cell Activation
PP405 is a dual inhibitor of the mitochondrial pyruvate carrier complex, targeting both the MPC1 and MPC2 subunits. Under normal conditions, the MPC transports pyruvate from the cytoplasm into the mitochondrial matrix, where it enters the tricarboxylic acid (TCA) cycle for oxidative metabolism.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take Finasteride with PP405?
Yes, Finasteride and PP405 can generally be taken together. Completely different mechanisms of action. Finasteride blocks DHT production via 5-alpha reductase inhibition, while PP405 targets hair follicle stem cell metabolism via MPC inhibition. Combination could be synergistic by addressing both hormonal miniaturization and stem cell dormancy simultaneously.
Is Finasteride and PP405 safe together?
Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.
What are the interactions between Finasteride and PP405?
Completely different mechanisms of action. Finasteride blocks DHT production via 5-alpha reductase inhibition, while PP405 targets hair follicle stem cell metabolism via MPC inhibition. Combination could be synergistic by addressing both hormonal miniaturization and stem cell dormancy simultaneously. This assessment has 90% confidence and is based on documented research data.
How should I time Finasteride and PP405?
Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and PP405 has a half-life of Topical application; exact pharmacokinetics not published. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.